Edwards Lifesciences to get $4.2 billion in cash for sale of critical-care group

By / / Finance / 1 minute of reading




Edwards said it plans to use the proceeds from the sale of the business to fund investments for growth, such as in technologies for aortic, mitral, tricuspid and pulmonic patients; and therapeutic areas for interventional heart failure.



Source link

About The Author

Avatar of Amanda Pierce
Amanda Pierce is a writer who has covered sports, education, and tech for Highland Loch Press. She also writes about her hobbies—which include hiking, traveling to new places, and cooking.

Start typing and press enter to search

Scroll to Top